Le Lézard
Classified in: Health, Business
Subjects: SVY, POL, AVO, CFG

/R E P E A T -- National Pharmacare must not impose new costs and taxes on small business/


TORONTO, June 12, 2019 /CNW/ - While small business owners are open to the idea of a national single-payer Pharmacare system in Canada, as recommended today by the Advisory Council on the Implementation of National Pharmacare, they strongly oppose funding it through payroll taxes or a GST increase, says the Canadian Federation of Independent Business (CFIB). Overall, 47 per cent of business owners support the introduction of a Pharmacare system, while 27 per cent are opposed.

"Prescription drug costs and insurance premiums are a major concern for small business owners, both for their employees and for themselves and their families," said CFIB president Dan Kelly. "A national Pharmacare system may be a benefit for the millions of Canadians who are self-employed or for small employers who cannot afford to offer coverage as an employee benefit. But the program shouldn't come as an additional tax burden for small business owners."

A majority of small business owners who support the implementation of a Pharmacare plan are opposed to funding the plan through a GST increase (85 per cent), payroll taxes (72 per cent), or increases in personal income taxes (72 per cent). Business owners agree that the plan should be funded through cost savings from negotiating lower drug prices (84 per cent) and by reallocating funds by cutting existing spending (72 per cent).

The report released by the Advisory Council estimates that the plan would come at a cost of $15.3 billion by 2027, when fully phased in.

"The money for Pharmacare has to come from somewhere," added Kelly. "We strongly oppose adding this cost to the mounting financial pressure already placed on small business owners by the government. If the government proceeds with the plan, we urge them to work diligently with the provinces to find cost-savings elsewhere to fund the plan to avoid putting additional pressures on Canadian taxpayers."

About CFIB
The Canadian Federation of Independent Business (CFIB) is Canada's largest association of small and medium-sized businesses with 110,000 members across every industry and region. CFIB is dedicated to increasing business owners' chances of success by driving policy change at all levels of government, providing expert advice and tools, and negotiating exclusive savings. Learn more at cfib.ca.

SOURCE Canadian Federation of Independent Business


These press releases may also interest you

at 05:35
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, has begun enrolling patients in the US for in a Phase 2b/3 clinical...

at 05:30
Blockbuster growth in weight-loss drugs was the main driver of a 13.5% increase in spending on prescription medications in the U.S. in 2023, according to ASHP's (American Society of Health-System Pharmacists) report, National Trends in Prescription...

at 05:26
Renowned orthopedic surgeon Dr. Dror Paley, in partnership with Dr. León Mora and the Cora Group Excellence Center for Orthopedic Reconstructive and Limb Lengthening Surgery, is...

at 05:15
The Industrial Technology Research Institute (ITRI) triumphed at the recent Edison Awardstm in Fort Myers, Florida, securing recognition for four exceptional technological breakthroughs: the Novel Dual-Targeted Therapy for Glaucoma, Key Functional...

at 05:00
The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024 to 2029 according to a report published by MarketsandMarketstm. The growth of the beta-glucan market is...

at 05:00
Geekplus, the global leader in mobile robot and smart logistics solutions, has deployed the first Shelf-to-Person PopPick project in the Nordics for one of the biggest online pharmacy wholesalers in the region, Med24.dk. System Teknik partnered on...



News published on and distributed by: